Works matching IS 02704137 AND DT 2004 AND VI 60 AND IP 1

Results: 8

Leveling of prostate cancer mortality in Western Europe.

Published in:

Prostate, 2004, v. 60, n. 1, p. 46, doi. 10.1002/pros.20058

By:

Fabio Levi;
Franca Lucchini;
Eva Negri;
Peter Boyle

Publication type:

Article

Immunological monitoring during combination of patient-oriented peptide vaccination and estramustine phosphate in patients with metastatic hormone refractory prostate cancer.

Published in:

Prostate, 2004, v. 60, n. 1, p. 32, doi. 10.1002/pros.20011

By:

Masanori Noguchi;
Kyogo Itoh;
Shigetaka Suekane;
Akiko Morinaga;
Aki Sukehiro;
Norie Suetsugu;
Kazuko Katagiri;
Akira Yamada;
Shinshi Noda

Publication type:

Article

Regulation of interleukin-6-mediated PI3K activation and neuroendocrine differentiation by androgen signaling in prostate cancer LNCaP cells (Shaozhen Xie and Hui-Kuan Lin contributed equally to the study.).

Published in:

Prostate, 2004, v. 60, n. 1, p. 61, doi. 10.1002/pros.20048

By:

Shaozhen Xie;
Hui-Kuan Lin;
Jing Ni;
Lin Yang;
Liang Wang;
P. Anthony di Sant'Agnese;
Chawnshang Chang

Publication type:

Article

The ErbB signaling network is coordinately expressed and activated in the mouse prostate.

Published in:

Prostate, 2004, v. 60, n. 1, p. 68, doi. 10.1002/pros.20042

By:

Yun Zhu;
Frank E. Jones

Publication type:

Article

FGF17 is an autocrine prostatic epithelial growth factor and is upregulated in benign prostatic hyperplasia.

Published in:

Prostate, 2004, v. 60, n. 1, p. 18, doi. 10.1002/pros.20026

By:

Nathaniel Polnaszek;
Bernard Kwabi-Addo;
Jianghua Wang;
Michael Ittmann

Publication type:

Article

Heterogeneous gene methylation patterns among pre-invasive and cancerous lesions of the prostate: A histopathologic study of whole mount prostate specimens.

Published in:

Prostate, 2004, v. 60, n. 1, p. 25, doi. 10.1002/pros.20013

By:

Karen Woodson;
John Gillespie;
Jeffrey Hanson;
Mike Emmert-Buck;
John M. Phillips;
W. Marston Linehan;
Joseph A. Tangrea

Publication type:

Article

Potent antitumor activity after systemic delivery of a doubly fusogenic oncolytic herpes simplex virus against metastatic prostate cancer.

Published in:

Prostate, 2004, v. 60, n. 1, p. 53, doi. 10.1002/pros.20056

By:

Mikihito Nakamori;
Xinping Fu;
Curtis A. Pettaway;
Xiaoliu Zhang

Publication type:

Article

Therapeutic potential of curcumin in prostate cancerIV: Interference with the osteomimetic properties of hormone refractory C4-2B prostate cancer cells.

Published in:

Prostate, 2004, v. 60, n. 1, p. 1, doi. 10.1002/pros.10359

By:

Thambi Dorai;
Janice P. Dutcher;
David W. Dempster;
Peter H. Wiernik

Publication type:

Article